
    
      The study will utilize the market released Reveal LINQâ„¢ Insertable Cardiac Monitor with an
      investigational ALLEVIATE-HF RAMware download. The study will enroll up to 300 subjects at up
      to 30 sites in the US, and will characterize the safety of the patient management pathway.
      Subjects will be followed for a minimum of 7 months, and until study closure.
    
  